loadpatents
Patent applications and USPTO patent grants for McCaffery; Ian.The latest application filed is for "anti-cd73 antibodies".
Patent | Date |
---|---|
Anti-cd73 Antibodies App 20210221905 - Griffin; Emily Piccione ;   et al. | 2021-07-22 |
Methods of treating cancer Grant 11,040,040 - Hotson , et al. June 22, 2 | 2021-06-22 |
Methods Of Treating Cancer App 20210154199 - Willingham; Stephen ;   et al. | 2021-05-27 |
Methods For Treating Cd73hi Tumors App 20210107989 - GRIFFIN; Emily Piccione ;   et al. | 2021-04-15 |
Methods of treating cancer Grant 10,912,776 - Willingham , et al. February 9, 2 | 2021-02-09 |
Adenosine Pathway Inhibitors For Cancer Treatment App 20210008206 - Miller; Richard A. ;   et al. | 2021-01-14 |
Anti-CD73 antibodies Grant 10,793,636 - Griffin , et al. October 6, 2 | 2020-10-06 |
Methods Of Treating Cancer App 20200297728 - Hotson; Andrew ;   et al. | 2020-09-24 |
Combination Therapy For Cancer Treatment App 20200261462 - Miller; Richard A. ;   et al. | 2020-08-20 |
Methods Of Treating Cancer App 20190076433 - Willingham; Stephen ;   et al. | 2019-03-14 |
Methods Of Treating Cancer App 20190022096 - Willingham; Stephen ;   et al. | 2019-01-24 |
Pancreatic cancer targets and uses thereof Grant 8,865,413 - Domon , et al. October 21, 2 | 2014-10-21 |
Methods And Compositions Relating To Inhibition Of Igf-1r App 20140037642 - McCaffery; Ian ;   et al. | 2014-02-06 |
Colon Cancer Targets And Uses Thereof App 20130067608 - DOMON; Bruno ;   et al. | 2013-03-14 |
Pancreatic Cancer Targets And Uses Thereof App 20120128677 - DOMON; Bruno ;   et al. | 2012-05-24 |
Colon Cancer Targets And Uses Thereof App 20110296544 - DOMON; Bruno ;   et al. | 2011-12-01 |
Colon cancer targets and uses thereof Grant 7,960,100 - Domon , et al. June 14, 2 | 2011-06-14 |
Colon disease targets and uses thereof Grant 7,776,555 - Domon , et al. August 17, 2 | 2010-08-17 |
Pancreatic cancer targets and uses thereof App 20090138977 - Domon; Bruno ;   et al. | 2009-05-28 |
Pancreatic cancer targets and uses thereof Grant 7,473,531 - Domon , et al. January 6, 2 | 2009-01-06 |
Pancreatic cancer secreted targets and uses thereof App 20080219992 - Alving; Kim ;   et al. | 2008-09-11 |
Selective capture and enrichment of proteins expressed on the cell surface App 20080076907 - Domon; Bruno ;   et al. | 2008-03-27 |
Selective capture and enrichment of proteins expressed on the cell surface Grant 7,348,416 - Domon , et al. March 25, 2 | 2008-03-25 |
Method and compositions for the treating diseases targeting E-cadherin App 20070059757 - Domon; Bruno ;   et al. | 2007-03-15 |
Selective capture and enrichment of proteins expressed on the cell surface App 20060154332 - Domon; Bruno ;   et al. | 2006-07-13 |
Method and compositions for treating diseases targeting CD71 App 20060039907 - Domon; Bruno ;   et al. | 2006-02-23 |
Method and compositions for treating diseases targeting CD51 App 20060035239 - Domon; Bruno ;   et al. | 2006-02-16 |
Diagnosis of pancreatic cancer by using pancreatic targets App 20060029987 - Domon; Bruno ;   et al. | 2006-02-09 |
Method and compositions for treating diseases targeting E-cadherin App 20060029988 - Domon; Bruno ;   et al. | 2006-02-09 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.